Table 1 Clinical characteristics of the study groups.
From: Mucosal immunity in health care workers’ respiratory tracts in the post-COVID-19 period
Group Parameter | Age M ± SD | BMI M ± SD | Charlson Comorbidity Index Me (Q1; Q3) |
|---|---|---|---|
Severe disease | 55.1 ± 6.3** | 32.4 ± 3.8** | 2 (1;3)* |
Moderate-to-severe disease | 52.2 ± 10.2** | 29.2 ± 6.1 | 1 (2;1)* |
Mild/asymptomatic disease | 39.5 ± 13.2 | 27.6 ± 6.8 | 0 (0;1) |
No history of COVID-19 | 44.9 ± 13.2 | 28.2 ± 6.5 | 1 (0;2) |